Mon panier

GDNF

GDNF Informations sur la molécule

Nom anglaisGlial cell line-derived neurotrophic factorsNombre de médicaments commercialisés0
Nombre de médicaments cliniques5Alias de la cibleGlial Cell Line-Derived Neurotrophic Factors
Phase de R&D la plus avancéeNDA/BLA
Nom anglaisGlial cell line-derived neurotrophic factors
Alias de la cibleGlial Cell Line-Derived Neurotrophic Factors
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques5
Phase de R&D la plus avancéeNDA/BLA

GDNF Liste de produits

  • Attribut

    Protein (5)

  • Bibliothèque de produits

    En ligne (5)

  • Espèces

    Human (4)Mouse (1)

  • Étiquette

    Tag Free (4)His Tag (1)

  • Marqueur

    Unconjugated (5)

GDNFContexte de la molécule

Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor that enhances survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake. GDNF is a glycosylated, disulfide-bonded homodimer that is a distantly related member of the transforming growth factor-beta superfamily. The GDNF family members (consists of GDNF, neurturin, artemin and persephin) are structurally similar to transforming growth factor-beta. Unlike other members of the TGF-beta superfamily, which signal through the receptor serine-threonine kinases, GDNF family ligands activate intracellular signalling cascades via the receptor tyrosine kinase Ret. GDNF family ligands binds to GDNF family receptor alpha (GFRalpha) and then the GDNF family ligand-GFR alpha complex binds to and stimulates autophosphorylation of Ret.

GDNFAlias de la molécule

GDNF,ATF

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
AAV2-GDNFAB-1005; AMT-140Phase 2 ClinicalLund University Foundation, National Institute Of Neurological Disorders And Stroke, Uniqure Biopharma Bv, Uc San FranciscoParkinson Disease; Multiple System Atrophy
Details
NRO-1NRO-1; SI-01Phase 2 ClinicalSenju Pharmaceutical Co LtdXerophthalmia
Details
AMT-130AAV5-miSNP15; AAV5-miSNP7; AMT-130; AAV5-miHtt12Phase 2 ClinicalAmsterdam Molecular Therapeutics, UniqureHuntington Disease
Details
AAV2-GDNF gene therapy (NINDS)Phase 1 ClinicalNational Institute Of Neurological Disorders And StrokeParkinson Disease
Details
RGL-193RGL-193Phase 1 ClinicalShanghai Regenelead Therapies Co LtdParkinson Disease
Details

Avis sur les produits

  • P***i2025-05-13
    0Mettre un like
    Acro Biosystems' GDNF recombinant protein has proven to be a reliable and high-quality reagent for research focused on neuronal development and maturation. In my study involving cortical projection neuron cultures, GDNF consistently supported neuronal survival, neurite outgrowth, and the expression of maturation markers. Its batch-to-batch consistency and biological activity have made it an essential component in our differentiation protocols. I highly recommend this product to laboratories engaged in both fundamental neuroscience research and translational studies aiming to model neurodegenerative diseases or explore neuroprotective strategies.
  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques